Literature DB >> 8473400

More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase.

L Wide1, O Bakos.   

Abstract

The purpose of this study was to compare the heterogeneity and median charge of FSH and LH in serum at different phases of the normal human menstrual cycle. Serum specimens were obtained during the follicular phase [9.0 +/- 1.9 (+/- SD) days before the midcycle], at the midcycle LH peak, and during the luteal phase (9.75 +/- 1.6 days after the midcycle) in 16 women with normal menstrual cycles. The 48 serum specimens were subjected to electrophoresis in 0.17% agarose suspension in 0.075 M veronal buffer at pH 8.6, using a column suitable for measuring the median charge of the isoforms of FSH and LH, expressed as median electrophoretic mobility. Four sera were also analyzed by use of a larger column, giving a high resolution. The FSH and LH activities were measured with a time-resolved sandwich fluoroimmunoassay. The number of isoforms of both FSH and LH in each serum specimen analyzed by electrophoresis with high resolution was between 20-30. The median charge of the isoforms of FSH was less negative (P < 0.001) at the midcycle than in the follicular or luteal phase in all 16 women. The same was found for LH in 14 of 15 women. The median charge of FSH or LH in the follicular phase was not significantly different from that in the luteal phase of the cycle. We conclude that at least 20-30 isoforms of both FSH and LH circulate in blood during the menstrual cycle. More basic isoforms of both hormones appear in serum at midcycle than in the follicular or luteal phase. The difference is most likely due to a selective secretion from the pituitary of more basic forms of FSH and LH at midcycle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473400     DOI: 10.1210/jcem.76.4.8473400

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma.

Authors:  R Guido; S Valenti; L Foppiani; D De Martini; M Cossu; M Giusti
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle.

Authors:  Arianna Pacchiarotti; Cesare Aragona; Renzo Gaglione; Helmy Selman
Journal:  J Assist Reprod Genet       Date:  2007-07-26       Impact factor: 3.412

3.  Receptor binding activity and in vitro biological activity of the human FSH charge isoforms as disclosed by heterologous and homologous assay systems: implications for the structure-function relationship of the FSH variants.

Authors:  E Zambrano; T Zariñán; A Olivares; J Barrios-de-Tomasi; A Ulloa-Aguirre
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

Review 4.  Novel pathways in gonadotropin receptor signaling and biased agonism.

Authors:  Alfredo Ulloa-Aguirre; Pascale Crépieux; Anne Poupon; Marie-Christine Maurel; Eric Reiter
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

5.  LH isoform profiles during short-term pulsatile LHRH administration in elderly men.

Authors:  M Giusti; S Valenti; R Guido; C M Cuttica; L Foppiani; G Giordano
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

6.  Macro- and Micro-heterogeneity in Pituitary and Urinary Follicle-Stimulating Hormone Glycosylation.

Authors:  George R Bousfield; Vladimir Y Butnev; Monica A Rueda-Santos; Alan Brown; Aaron Smalter Hall; David J Harvey
Journal:  J Glycomics Lipidomics       Date:  2014

Review 7.  Follicle-Stimulating Hormone Glycobiology.

Authors:  George R Bousfield; David J Harvey
Journal:  Endocrinology       Date:  2019-06-01       Impact factor: 4.736

8.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

9.  Hypo-glycosylated human follicle-stimulating hormone (hFSH(21/18)) is much more active in vitro than fully-glycosylated hFSH (hFSH(24)).

Authors:  George R Bousfield; Vladimir Y Butnev; Viktor Y Butnev; Yasuaki Hiromasa; David J Harvey; Jeffrey V May
Journal:  Mol Cell Endocrinol       Date:  2013-12-01       Impact factor: 4.102

10.  Menopause and the human hypothalamus: evidence for the role of kisspeptin/neurokinin B neurons in the regulation of estrogen negative feedback.

Authors:  Naomi E Rance
Journal:  Peptides       Date:  2008-05-28       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.